India’s startup ecosystem is experiencing a resurgence, driven by strategic depth and investor confidence rather than inflated valuations. Recently, Indian startups raised $272.1 million across 18 deals, marking a significant 38% increase in weekly capital inflow. Although the number of deals decreased by 28%, this indicates a focus on larger, more significant investments.
Healthtech, enterprise tech, and AI sectors are leading the charge, with Healthtech securing $65 million due to rising demand for tech-enabled healthcare solutions. Enterprise tech and consumer services also attracted substantial investments, while AI startups continued to gain investor trust, with early-stage AI ventures seeing a 23% year-on-year increase in median ticket size.
Notable deals included Truemeds’ $85 million Series C round, Zepto’s $46 million strategic funding, and Darwinbox’s $40 million Series D. Peak XV Partners emerged as the most active investor, participating in multiple deals. Early-stage funding also saw a resurgence, with seed-stage deals totaling $12.4 million, reflecting a shift towards sustainable ventures with clear monetization paths.
India’s IPO pipeline is gaining momentum, with Fractal filing for a significant listing and BlueStone’s public offering achieving a 2.7x oversubscription. The private market also witnessed robust fundraising activities, signaling a rebound in public market confidence.
Investors are now prioritizing startups with clear revenue models and ESG-aligned missions, focusing on sectors like transportation, logistics tech, retail, SaaS, agritech, EVs, AI, and healthtech. As macroeconomic conditions improve, strategic exits and listings are expected to increase by the end of 2025.
Overall, India’s startups raised $4.8 billion in the first half of 2025, and the outlook for the rest of the year remains strong. The focus has shifted from chasing unicorns to building lasting institutions, with resilience emerging as the key driver for growth.
